Sponsored Links
Lymphoma Information Network » Lymphoma Info » Extranodal NK or T Cell Lymphoma - Nasal

Extranodal NK or T Cell Lymphoma - Nasal

epstein barr virus
Leukemia cells that contain Epstein Barr virus, Dr. Paul Feorino, CDC

Extranodal NK/T-Cell Lymphoma is a cancer of the natural killer cells and/or T-cells found in the nasal cavity. This aggressive cancer is rare in the United States and affects mostly those of Asian or Latin American decent. Tumors usually occur in the naval cavity, though involvement of the skin, kidneys, gastrointestinal (GI) tract, and respiratory tract is not uncommon.

It is usually associated with the Epstein-Barr virus (mononucleosis). "Extranodal" denotes that it is found outside of the lymph nodes.

Diagnosis and Staging

Patients usually present with nose bleeds, nasal masses, or damage to the nose. If the disease has spread to other areas of the body, skin ulcers or GI perforation may also be symptoms. Diagnosis is made via biopsy. Staging is done with other tests, such as X-rays, PET scans, CT scans, and ultrasounds. Because the disease is extremely rare, there is no defined staging system in place.

Treatment

Treatments are currently being researched. New clinical trials are usually underway, so patients and doctors should consult the latest scientific literature to discover the most up-to-date treatment regimens. Common treatments include:

  • Chemotherapy using the CHOP regimen
  • Radiation used in combination with chemotherapy
  • Bone marrow/stem cell transplants are being researched as a treatment for extranodal NK/T cell lymphoma

Sponsored Links

Cancer Support Groups

SupportGroups.com build awareness and support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Other Lymphoma Pages

disclaimer

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.

Featured Treatment
searching for treatment

Featured Treatment: Zevalin®

Zevalin® (Ibritumomab tiuxetan) is a form of radioimmunotherapy (a radiolabeled monoclonal antibody) for treatment of patients with relapsed or refractory, low‑grade or follicular B‑cell non‑Hodgkin's lymphoma (NHL). "Refractory" refers to a disease that does not respond to treatment.

Zevalin is the first radioummunotherapy treatment to be FDA-approved as a first-line therapy for lymphoma. Read more...

Sponsored Links
User login
Cancer Support Groups

Cancer Support Groups

support groups

SupportGroups.com aims to build awareness and provide support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Poll
What is most important to you in an Online Support Group?:
Latest Blog Entries

Did You Know?
Since the early 1970s, incidence rates for non-Hodgkin’s lymphoma have nearly doubled. Incidence rates for Hodgkin’s disease have declined about 60%. Better means of diagnosis has also increased the number as doctors better understand cancer of lymphocytes verses other diseases.